Llwytho...
Esketamine clinical trials: reply to Maju et al.
Maju et al. provided clarifications on important and controversial issues related to esketamine clinical trial data, in response to a vivid debate triggered by the marketing authorisation recently granted by this new medicine. In this commentary, we reply to their comments attempting to critically d...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Epidemiol Psychiatr Sci |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Cambridge University Press
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7214734/ https://ncbi.nlm.nih.gov/pubmed/32345395 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1017/S204579602000027X |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|